convert
enzym
receptor
better
affin
sarscov
glycoprotein
entri
thu
block
bind
block
host
proteas
cleavag
releas
fusion
peptid
effici
strategi
prevent
coronaviru
entri
date
one
studi
assess
immunogen
structur
domain
recombin
protein
time
write
find
linear
epitop
remain
limit
bioinformat
predict
human
b
tcell
epitop
use
sarscov
model
five
region
glycoprotein
predict
associ
robust
immun
respons
studi
report
candid
epitop
requir
valid
human
patient
sampl
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
patient
identif
two
immunodomin
linear
bcell
epitop
glycoprotein
crucial
control
infect
total
convalesc
serum
sampl
collect
current
outbreak
singapor
screen
dilut
neutral
antibodi
pseudotyp
lentiviru
express
glycoprotein
tag
luciferas
report
figur
patient
test
six
patient
suffici
amount
serum
sampl
display
good
neutral
activ
select
function
character
sera
patient
show
similar
ic
rang
titr
except
patient
show
strongest
neutral
activ
ic
figur
next
assess
antigen
target
sera
use
linear
bcell
interestingli
two
distinct
peptid
pool
librari
pool
strongli
detect
sera
patient
recov
region
encompass
fusion
peptid
highli
conserv
among
coronavirus
suggest
potenti
pancoronaviru
epitop
locat
interestingli
target
region
also
demonstr
neutral
infect
pancoronaviru
fusion
inhibitor
peptid
surprisingli
linear
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
antibodi
target
region
mostli
conform
epitop
assess
individu
peptid
within
pool
narrow
specif
region
interest
peptid
respect
figur
recognit
region
stronger
peptid
sarscov
figur
togeth
find
suggest
linear
bcell
epitop
domin
antigen
region
corrobor
previou
bioinformat
predict
use
recent
publish
structur
protein
prefus
conform
peptid
local
proxim
rbd
figur
plausibl
antibodi
bind
region
may
steric
hinder
bind
receptor
therebi
abolish
viru
infect
anoth
possibl
could
alloster
effect
bind
similarli
peptid
contain
part
fusion
peptid
sequenc
may
potenti
affect
viru
fusion
figur
order
assess
import
region
control
infect
antibodi
deplet
assay
perform
figur
deplet
effici
specif
valid
elisa
show
antibodi
respect
peptid
deplet
unrel
antibodi
figur
interestingli
sera
deplet
antibodi
target
either
peptid
led
significantli
reduc
abil
neutral
pseudoviru
infect
compar
nondeplet
sera
control
figur
result
demonstr
two
bcell
linear
epitop
identifi
studi
immunodomin
deplet
assay
function
valid
antibodi
target
peptid
possess
signific
neutral
role
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
pseudotyp
lentivirus
importantli
also
assess
potenti
presenc
mutat
peptid
region
found
low
rate
mutat
low
moder
impact
viral
sequenc
mutat
viral
genom
sequenc
respect
supplementari
tabl
result
essenti
guid
design
evalu
effici
specif
serolog
assay
well
help
priorit
vaccin
target
design
unpreced
crisi
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
author
would
like
thank
professor
yeejoo
tan
depart
microbiolog
nu
kindli
provid
cell
plasmid
assoc
prof
brendon
hanson
defenc
scienc
organ
nation
laboratori
kindli
provid
plasmid
would
also
like
thank
studi
particip
donat
blood
sampl
project
healthcar
worker
care
patient
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
th
figur
antibodi
linear
bcell
epitop
neutral
ab
local
sequenc
specif
b
pancov
epitop
spike
protein
pdb
shown
monom
denot
either
pink
blue
orang
ce
pool
sera
patient
ad
plate
coat
correspond
peptid
deplet
specif
antibodi
c
nondeplet
peptidespecif
antibodydeplet
sera
subject
peptidebas
elisa
peptid
crossassay
data
deplet
sera
white
normal
percentag
nondeplet
sera
black
signal
pool
healthi
donor
sera
display
black
dot
line
data
shown
mean
sd
e
nondeplet
peptidespecif
antibodydeplet
pool
sera
mix
pseudoviru
incub
cell
h
percentag
neutral
pseudoviru
infect
rel
nondeplet
sera
shown
data
present
mean
sd
signal
pool
healthi
donor
sera
display
black
dot
line
statist
analysi
carri
onesampl
test
p
p
igg
control
e
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
th
http
doi
biorxiv
preprint
